Ractigen Therapeutics Breaking News Jefferies Initiates Coverage of NeoGenomics, Hologic, QuidelOrtho Akoya Biosciences Licenses Early-Stage Melanoma Test From NeraCare AmplifiDx Nabs $954K in RADx Funding for POC Test Instrument Development University of Melbourne, Peter MacCallum Cancer Centre Launch Precision Oncology JV Quantum-Si Regains Compliance With Nasdaq Listing Requirements
